Abstract
Golimumab (Simponi (R)), a fully human monoclonal antibody against tumour necrosis factor-alpha (TNF alpha), is given once monthly by subcutaneous inj......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
